EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring medication experiences, behaviours, and reminder technology preferences in people with Parkinson's disease: a survey

Emma Packer, Héloïse Debelle, Annette Hand, Lynn Rochester, Alison J Yarnall, Lisa Alcock, Silvia Del Din

Frontiers in Digital Health · 30.07.2026 · 8

DOI: 10.3389/fdgth.2026.1839031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Digital Health, online erschienen am 30.07.2026. Verfasst von Emma Packer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Due to complex medication regimens, suboptimal medication adherence is common among people with Parkinson’s disease (PwP), leading to poor symptom control. Medication reminder technology, and a deeper understanding of individual’s medication experiences and behaviours offer promising solutions, but these factors need to be explored in PwP. An online survey was developed to identify the current potential use of medication reminder technology in PwP; determine the essential features of the ideal medication reminder technology; compare feature preferences between current medication reminder technology users and non-users; and Explore Respondents Medication Experiences and Behaviour.

Methods

The survey was open to individuals over 18, with a PD diagnosis and taking oral PD medication. The survey consisted of 51 primary questions exploring PwP medication experiences and behaviours; current/potential use of medication reminder technology; and designing ideal medication reminder technology. Descriptive statistics, and statistical tests compared questionnaire responses. To categorise free-text responses, inductive and deductive content analysis was performed.

Results

Data from 283 PwP (median age: 65 years, 46% female) was analysed. Thirty-four percent were non-adherent to their PD medication regimen, and respondents with more negative medication beliefs and perceived medication complexity had worse medication adherence. Fifty percent of respondents already used medication reminder technology, with these respondents most commonly using smartphones (72%). Respondents who already used medication reminder technology scored significantly higher on the medication adherence rating scale (MARS-5). When choosing the ideal medication reminder technology, smartwatches were the preferred device (57%). When designing the ideal medication reminder smartwatch, no features were deemed ‘essential’ to all respondents, with great heterogeneity in preferences. Overall, smartwatch usability and functionality was more important to respondents than appearance, and current users of reminder technology placed greater importance on smartwatch usability than non-users.

Discussion

Medication reminder technology, such as smartwatches, may support medication adherence in PwP, but this technology must be personalised to user needs, and developed with an emphasis on usability and functionality, over aesthetics. When developing this technology, PwP should be included as co-developers, and the process should be iterative. However, reminder technology alone may not sufficiently support adherence, and additional patient-related factors need to be overcome.

Schlagwörter

Stichwörter der Autor:innen

Parkinson'sadherencemedicationneurodegenerationwearables

Autor:innen und Institutionen

  • Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Research Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, United Kingdom.
  • School of Healthcare and Nursing Science, Northumbria University, Newcastle upon Tyne, United Kingdom.
  • The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
  • National Institute for Health and Care Research (NIHR) Newcastle Biomedical Research Centre (BRC), Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, United Kingdom.

Förderung

  • Wellcome Trust

Zitieren

APA

Packer, E., Debelle, H., Hand, A., Rochester, L., Yarnall, A. J., Alcock, L., & Del Din, S. (2026). Exploring medication experiences, behaviours, and reminder technology preferences in people with Parkinson's disease: a survey. Frontiers in Digital Health, 8. https://doi.org/10.3389/fdgth.2026.1839031

Vancouver

Packer E, Debelle H, Hand A, Rochester L, Yarnall AJ, Alcock L, et al. Exploring medication experiences, behaviours, and reminder technology preferences in people with Parkinson's disease: a survey. Frontiers in Digital Health. 2026;8. doi:10.3389/fdgth.2026.1839031

BibTeX
@article{Packer2026,
  author = {Packer, Emma and Debelle, Héloïse and Hand, Annette and Rochester, Lynn and Yarnall, Alison J and Alcock, Lisa and Del Din, Silvia},
  title = {Exploring medication experiences, behaviours, and reminder technology preferences in people with Parkinson's disease: a survey},
  journal = {Frontiers in Digital Health},
  year = {2026},
  volume = {8},
  doi = {10.3389/fdgth.2026.1839031}
}
Kostenlos starten →